| Name | 5-(1H-benzimidazol-2-yl)-2-methylaniline |
|---|---|
| Synonyms | 5-benzimidazol-2-yl-2-methylphenylamine |
| Molecular Formula | C14H13N3 |
|---|---|
| Molecular Weight | 223.27300 |
| Exact Mass | 223.11100 |
| PSA | 54.70000 |
| LogP | 3.70170 |
| HS Code | 2933290090 |
|---|
|
~%
292644-33-8 |
| Literature: ASTRAZENECA AB; ASTRAZENECA UK LIMITED Patent: WO2009/27746 A1, 2009 ; Location in patent: Page/Page column 60-61 ; WO 2009/027746 A1 |
|
~66%
292644-33-8 |
| Literature: TRAGEX PHARMA; HADJ-SLIMANE, Reda; GARBAY, Christiane Patent: WO2012/156289 A1, 2012 ; Location in patent: Page/Page column 30-31 ; |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933290090 |
|---|---|
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |